Opportunity ID: 351847

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-25-060
Funding Opportunity Title: High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jan 17, 2024
Last Updated Date: Jan 17, 2024
Original Closing Date for Applications: Feb 11, 2027
Current Closing Date for Applications: Feb 11, 2027
Archive Date: Mar 19, 2027
Estimated Total Program Funding:
Award Ceiling: $1,500,000
Award Floor:

Eligibility

Eligible Applicants: City or township governments
Private institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Special district governments
Public housing authorities/Indian housing authorities
State governments
County governments
Public and State controlled institutions of higher education
Small businesses
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use. This FOA is open to both individual researchers and research teams and includes all areas of research from basic science to clinical and implementation research. All studies must focus on NIH HIV/AIDS Research Priorities: NOT-OD-20-018: UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-060.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 351847 Full Announcement-RFA-DA-25-060 -> RFA-DA-25-060-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or before January 24, 2025 PKG00284451 Jul 15, 2024 Jan 24, 2025 View
FORMS-I Use for due dates on or after January 25, 2025 PKG00289119 Nov 26, 2024 Feb 11, 2027 View

Package 1

Mandatory forms

351847 RR_SF424_5_0-5.0.pdf

351847 PHS398_CoverPageSupplement_5_0-5.0.pdf

351847 RR_OtherProjectInfo_1_4-1.4.pdf

351847 PerformanceSite_4_0-4.0.pdf

351847 RR_KeyPersonExpanded_4_0-4.0.pdf

351847 RR_Budget_3_0-3.0.pdf

351847 PHS398_ResearchPlan_5_0-5.0.pdf

351847 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351847 RR_SubawardBudget30_3_0-3.0.pdf

351847 PHS_AssignmentRequestForm_4_0-4.0.pdf

Package 2

Mandatory forms

351847 RR_SF424_5_0-5.0.pdf

351847 PHS398_CoverPageSupplement_5_0-5.0.pdf

351847 RR_OtherProjectInfo_1_4-1.4.pdf

351847 PerformanceSite_4_0-4.0.pdf

351847 RR_KeyPersonExpanded_4_0-4.0.pdf

351847 RR_Budget_3_0-3.0.pdf

351847 PHS398_ResearchPlan_5_0-5.0.pdf

351847 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

351847 RR_SubawardBudget30_3_0-3.0.pdf

351847 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T03:13:21-05:00

Share This Post, Choose Your Platform!

About the Author: